ClinicalTrials.govpublic full text
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
schizophrenia agitation, schizo affective disorder, bipolar disorder, dexmedetomidine, agitation, schizophrenia, schizoaffective disorder, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879944
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.